Preparation of pyrazole derivatives as p38 MAP kinase inhibitors and cytokine production inhibitors.

  • Hagihara M
  • Shibakawa N
  • Nishihara M
  • et al.
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Abstract

The title compds. I [R1 is optionally substituted phenyl; R2 is H, halogeno, alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, or substituted amino; Q is CH or N; R3 is H, alkyl, or amino; and R4 is a group represented by the general formula Q1, etc.; R7 is H or alkyl; R8 is H, alkyl, or substituted amino; R9 is H or alkyl] are prepd. Compds. of this invention in vitro showed IC50 values of 0.2 nM to 8.8 nM against p38 MAP kinase. Formulations are given. [on SciFinder(R)]

Cite

CITATION STYLE

APA

Hagihara, M., Shibakawa, N., Nishihara, M., Shirai, T., Shimizu, M., Hasegawa, T., … Wada, Yukinori. (2004, April 8). Preparation of pyrazole derivatives as p38 MAP kinase inhibitors and cytokine production inhibitors. PCT Int. Appl. Ube Industries, Ltd., Japan .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free